Dudediligence.

Sonoma Pharmaceuticals, Inc

SNOANASDAQ · Surgical & Medical Instruments & Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$3.6MSep ’24$3.6MDec ’24$3.8MMar ’25$4.0MJun ’25$5.6MSep ’25$4.3MDec ’25$5.6MMar ’26$6.4MJun ’26
Net income, by quarter
−$610,000Sep ’24−$928,000Dec ’24−$776,000Mar ’25−$1.2MJun ’25−$534,000Sep ’25−$819,000Dec ’25−$581,000Mar ’26−$330,000Jun ’26
Fiscal years, by the month each ended
LineMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue$12.6M$13.3M$12.7M$14.3M$19.5M
Gross profit$4.0M$4.5M$4.7M$5.5M$7.4M
Operating income−$5.9M−$4.6M−$4.7M−$3.7M−$2.5M
Net income−$5.1M−$5.2M−$4.8M−$3.5M−$3.2M
Operating cash flow−$4.2M−$6.2M−$2.4M−$88,000−$3.9M
Free cash flow−$4.4M−$6.4M−$2.4M−$168,000−$4.1M
Cash$7.4M$3.8M$3.1M$5.4M$2.4M
Debt$0.00$431,000$323,000$220,000$222,000
Shares outstanding3.1M4.9M780.4K1.6M1.8M